|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Short-term administration of the bisphosphonate ibandrouate increases bone volume and prevents by perparathyroad bone changes in mild inexperimental renal failure显示文摘 | Geng Z Monier-Faugere MC Bauss F | 2000 | Cliu Nephrol2000，54，1： | 1 |
| 2 | Tumor necrosis factor mediates endotoxic effects in mice显示文摘 | Bauss F Droge W Mannel D N | 1987 | Infect Immun1987，55，7： | 1 |
| 3 | New model for simulation of fracture repair in full-grown beagle dogs : model characterization and results from a long-term study with ibandronate显示文摘 | Bauss F Schenk RK H6rt S | 2004 | J Pharmacol Toxicol Methods2004，50，1： | 1 |
| 4 | Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents by perparathyroad bone changes in mild inexperimental renal failure显示文摘 | Geng Z Monier-Faugere M C Bauss F | 2000 | Clin Nephrol2000，54，1： | 1 |
| 5 | Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats显示文摘 | BAUSS F WAGNER M HoOTHORN L H | 2002 | J Rheumatol2002，29，： | 1 |
| 6 | Ibandronate,a potent new bisphosphonate to inhibit bone rseorption显示文摘 | Bauss F S chenk R | 1991 | J Bone Miner Res1991，6，9： | 1 |
| 7 | Preclinical perspectives on bisphosphonate renal safety 显示文摘 | Body JJ Pfister T Bauss F | 2005 | The Oncologist2005，10，1： | 1 |
| 8 | Short--term ad ministration of the bisphosphonate ibandronate increases bone volume and prevents by perparathyroad bone changes in mild in- experimental renal failure 显示文摘 | Geng Z Monier-Faugere M C Bauss F | 2000 | Clin Nephrol2000，54，1： | 1 |
| 9 | Effects of treatment with Ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of Ibandronate in ovariectomized aged rats显示文摘 | Lalla S Endele R | 2002 | J Rheamalol2002，29，10： | 1 |
| 10 | Ibandronate:a clinical pharmacological and pharmacokinetic update显示文摘 | Barrett J Worth E Bauss F | 2004 | J Clin Pharmacol2004，44，9： | 1 |
| 11 | Effect of 17beta-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17beta-estradiol serum kinetics and bone mass in rats 显示文摘 | Bauss F Esswein F Reiff K | 1996 | Calcif Tissue Int1996，59，3： | 1 |
| 12 | Effect of 17beta-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17beta-estradiol serum kinetics and bone mass in rats显示文摘 | Bauss F Esswein A Reiff K | 1996 | Calcif Tissue Int1996，59，3： | 1 |
| 13 | Ibandronate in metastatic bone disease:a review of preclinical data显示文摘 | Bauss F Body JJ | 2005 | Anticancer Drugs2005，16，2： | 1 |
| 14 | Tumor necrosis factor mediates endotoxic effects in mice 显示文摘 | Bauss F Droge W Mannel D N | 1987 | Infect Immune1987，55，7： | 1 |
| 15 | Bandronate in metastatic bone disease:a review of preclinical data显示文摘 | Bauss F Ody JJ | 2005 | Anticancer Drugs2005，6，： | 1 |
| 16 | Short-term administration of the bisphosphonate ibandronate increase bone volume and prevents by perparathyroad bone changes in mild in experimental renal failure显示文摘 | Geng Z Monier-Faugre MC Bauss F | 2000 | Clin Nephrol2000，54，1： | 1 |
| 17 | Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats显示文摘 | Bauss F Lalla S Endele R | 2002 | J Rheumatol2002，29，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员